272 related articles for article (PubMed ID: 36717900)
1. Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma.
Liu D; Yang F; Zhang T; Mao R
J Transl Med; 2023 Jan; 21(1):57. PubMed ID: 36717900
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and immune landscape of KIR2DL4 and the senescence-based signature in cutaneous melanoma.
Mao R; Ren Z; Yang F; Yang P; Zhang T
Cancer Sci; 2022 Nov; 113(11):3947-3959. PubMed ID: 35848898
[TBL] [Abstract][Full Text] [Related]
3. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
Song S; Zhang M; Xie P; Wang S; Wang Y
Front Immunol; 2022; 13():978909. PubMed ID: 36341328
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma.
He F; Zeng P; Ma S; Yang X; Liu H; Liu Q; Zhou Y; Zhu H
Front Pharmacol; 2023; 14():1088993. PubMed ID: 36843949
[No Abstract] [Full Text] [Related]
6. Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma.
Cai Z; He Y; Yu Z; Hu J; Xiao Z; Zu X; Li Z; Li H
Front Immunol; 2022; 13():933241. PubMed ID: 36211378
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of cuproptosis-related genes in prognosis, tumor microenvironment infiltration, and immunotherapy response in gastric cancer.
Nie H; Wang H; Zhang M; Ning Y; Chen X; Zhang Z; Hu X; Zhao Q; Chen P; Fang J; Wang F
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5453-5468. PubMed ID: 36462036
[TBL] [Abstract][Full Text] [Related]
8. The role of cuproptosis-related gene in the classification and prognosis of melanoma.
Liu JY; Liu LP; Li Z; Luo YW; Liang F
Front Immunol; 2022; 13():986214. PubMed ID: 36341437
[TBL] [Abstract][Full Text] [Related]
9. Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.
Wang L; Yao B; Yang J; Tian Z; He J
BMC Cancer; 2022 Nov; 22(1):1131. PubMed ID: 36333684
[TBL] [Abstract][Full Text] [Related]
10. Identification of cuproptosis-related patterns and construction of a scoring system for predicting prognosis, tumor microenvironment-infiltration characteristics, and immunotherapy efficacy in breast cancer.
Li W; Zhang X; Chen Y; Pang D
Front Oncol; 2022; 12():966511. PubMed ID: 36212436
[TBL] [Abstract][Full Text] [Related]
11. Construction and validation of a cuproptosis-related prognostic model for glioblastoma.
Zhang B; Xie L; Liu J; Liu A; He M
Front Immunol; 2023; 14():1082974. PubMed ID: 36814929
[TBL] [Abstract][Full Text] [Related]
12. The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma.
Wang W; Lu Z; Wang M; Liu Z; Wu B; Yang C; Huan H; Gong P
Front Immunol; 2022; 13():998236. PubMed ID: 36110851
[TBL] [Abstract][Full Text] [Related]
13. Identification of cuproptosis-related subtypes, characterization of immune microenvironment infiltration, and development of a prognosis model for osteoarthritis.
Nong J; Lu G; Huang Y; Liu J; Chen L; Pan H; Xiong B
Front Immunol; 2023; 14():1178794. PubMed ID: 37809099
[TBL] [Abstract][Full Text] [Related]
14. Cuproptosis regulator-mediated patterns associated with immune infiltration features and construction of cuproptosis-related signatures to guide immunotherapy.
Wang G; Xiao R; Zhao S; Sun L; Guo J; Li W; Zhang Y; Bian X; Qiu W; Wang S
Front Immunol; 2022; 13():945516. PubMed ID: 36248857
[TBL] [Abstract][Full Text] [Related]
15. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma.
Li J; Yin J; Li W; Wang H; Ni B
Cancer Cell Int; 2023 Jan; 23(1):7. PubMed ID: 36647100
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer.
Pan Y; Zhang Q; Zhang H; Kong F
Funct Integr Genomics; 2023 Jan; 23(1):38. PubMed ID: 36640225
[TBL] [Abstract][Full Text] [Related]
17. Cuproptosis illustrates tumor micro-environment features and predicts prostate cancer therapeutic sensitivity and prognosis.
Cheng B; Tang C; Xie J; Zhou Q; Luo T; Wang Q; Huang H
Life Sci; 2023 Jul; 325():121659. PubMed ID: 37011878
[TBL] [Abstract][Full Text] [Related]
18. Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer.
Song Q; Zhou R; Shu F; Fu W
Front Immunol; 2022; 13():958368. PubMed ID: 35990642
[TBL] [Abstract][Full Text] [Related]
19. A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma.
Zhou Y; Shu Q; Fu Z; Wang C; Gu J; Li J; Chen Y; Xie M
Front Genet; 2022; 13():959456. PubMed ID: 35938036
[TBL] [Abstract][Full Text] [Related]
20. Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma.
Zhang L; Xu J; Chu X; Zhang H; Yao X; Zhang J; Guo Y
BMC Bioinformatics; 2022 Nov; 23(1):485. PubMed ID: 36384423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
